Publications by authors named "Timothy Levar"
Article Synopsis
- The evolving landscape of biologic treatments for inflammatory bowel disease (IBD) requires surgeons to stay informed for effective, multi-disciplinary care.
- A systematic review selected 38 out of 1,020 articles focusing on novel therapies, particularly JAK inhibitors and IL-23p19 inhibitors, which showed efficacy for ulcerative colitis and Crohn's colitis respectively, despite some patients not responding.
- The findings suggest that while these novel agents are effective as subsequent treatment options, further research with robust designs is necessary to improve treatment outcomes for IBD-associated colitis.
